Search results
Showing 2086 to 2100 of 2172 results for technology appraisal
Early Cancer Diagnosis: 75% of cases diagnosed at stage 1 or 2 by 2028.
The guidance development timeline
Information and benefits about shared decision making. Includes links to patient decision aids.
Our stakeholders are involved in the development of NICE guidance and quality standards to ensure that the recommendations are relevant, practical, and meet the needs of those affected by the health or social care issues addressed.
NICE works with partners including Public Health England, NHS England and NHS Improvement to assess services and support innovation and best practice.
Hypertension case finding and optimal management and lipid optimal management
England Statin intolerance pathway brings together multiple NICE guidance and technology appraisals into a single document,...
NICE Advice works closely with our system partners and industry to drive innovation into the hands of health and care professionals, to enable best practice.
Evidence standards framework (ESF) for digital health technologies
NICE standards for innovators of digital health technologies and NHS commissioners
Science policy projects with NICE.
We're at the forefront of bringing better care to people. We help practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal
These are the main stages in the multiple technology appraisal process used before April 2018.
Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.
Our content assurance service. Includes what the service offers, how to apply and pricing.
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies